Arbor Rapha Capital Bioholdings I (Arbor Rapha Capital Bioholdings I) GF Value Rank : 0 (As of Jun. 14, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Arbor Rapha Capital Bioholdings I GF Value Rank?

Arbor Rapha Capital Bioholdings I has the GF Value Rank of 0.

The GF Value Rank is determined by the price-to-GF-Value (P/GF Value) ratio, a proprietary metric calculated based on historical multiples along with an adjustment factor based on a company's past returns and growth and future estimates of the business' performance.

GuruFocus found that for valuation, we cannot simply give stocks a better GF Value rank simply because they have a lower P/GF Value ratio. Backtesting shows that over the long term, the two worst-performing groups are the most expensive group (with the highest P/GF Value ratio) and the least expensive group (with the lowest P/GF Value ratio).

We can understand why the most expensive group underperforms. We were initially puzzled by the underperformance of the least expensive group, but we realized there is a reason why some stocks are super cheap. If they look too undervalued, it is often because the businesses behind them are poor quality. The market realized this and gave them low valuations. In a way, the market is efficient.

After multiple backtesting analyses, we granted the stocks in third-cheapest percentile the highest GF Value rank, as they have performed the best over a full market cycle. Stock performance is actually not as sensitive to valuation as it is to growth and profitability. On average, the companies in the 20%-50% valuation groups have similar performances. Therefore, we should avoid the most expensive and the least expensive stocks. We can be more tolerant of valuation.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Arbor Rapha Capital Bioholdings I GF Value Rank Related Terms

Thank you for viewing the detailed overview of Arbor Rapha Capital Bioholdings I's GF Value Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Arbor Rapha Capital Bioholdings I (Arbor Rapha Capital Bioholdings I) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Arbor Rapha Capital Bioholdings Corp I (NAS:ARCK) » Definitions » GF Value Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

333 Earle Ovington Boulevard, Suite 900, Uniondale, NY, USA, 11553

Website

https://arcbiocorp.com

Arbor Rapha Capital Bioholdings Corp I is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

Executives

Ralph Mack	director	333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553
Kevin M. Slawin	director, officer: Chief Strategy Officer	C/O BELLICUM PHARMACEUTICALS, INC., 2130 W. HOLCOMBE BLVD., STE. 800, HOUSTON TX 77030
Ivan Kaufman	director, 10 percent owner, officer: Chief Executive Officer
Arbor Commercial Mortgage Llc	director, 10 percent owner, officer: Chief Executive Officer	333 EARLE OVINGTON BLVD, STE 900, UNIONDALE NY 11553
Paul Elenio	officer: Chief Financial Officer	C/O ARBOR REALTY TRUST, 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553
John Natalone	officer: Treasurer	C/O ARBOR REALTY TRUST, INC., 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553
William P Connolly	officer: Secretary & Vice President	C/O ARBOR REALTY TRUST INC., 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553
Cyrus D. Walker	director	C/O MARIPOSA CAPITAL, LLC, 500 SOUTH POINTE DRIVE, SUITE 240, MIAMI BEACH FL 33139
Arbor Rapha Capital Llc	director, 10 percent owner, officer: Chief Executive Officer	333 EARLE OVINGTON BLVD., SUITE 900, UNIONDALE NY 11553
Avery Modlin	director	C/O ARBOR REALTY TRUST INC., 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553

Arbor Rapha Capital Bioholdings I (Arbor Rapha Capital Bioholdings I) Headlines

From GuruFocus

Arbor Rapha Capital Bioholdings Corp. I Announces the Separate Trading of its Shares of Class A Common Stock and Redeemable Warrants Commencing December 20, 2021

By PRNewswire PRNewswire • 12-17-2021

Arbor Rapha Capital Bioholdings Corp. I Announces Closing of $172.5 Million Initial Public Offering

By PRNewswire PRNewswire • 11-02-2021